Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Study to Determine the Proportion and Clinical Characteristics of COPD Patients With Asthma Symptoms in Asia (ACOS) and Describe Current Practices in Diagnosis and Management

NCT02878252 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02878252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02878252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Study to Determine the Proportion and Clinical Characteristics of COPD Patients With Asthma Symptoms in Asia (ACOS) and Describe Current Practices in Diagnosis and Management
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 4, 2016
Completion date
April 28, 2017
Enrollment
350 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

patients with asthma-copd overlap syndrome (acos)